HJLI News and Press, Hancock Jaffe Laboratories Inc. From 07/17/20

Hancock Jaffe Laboratories ( HJLI +0.8% ) prices $5.6M offering , which includes underwritten public offering and private placement of units. More news on: Hancock Jaffe Laboratories, Inc., Healthcare stocks news, , Read more ...

IRVINE, CA / ACCESSWIRE / July 17, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced the pricing of a $5.6 million offering, which consisted of an underwritten public offering of units and a priva...

Hancock Jaffe Laboratories ( HJLI +24.3% ) has entered into a securities purchase agreement to purchase ~$1.33M of its common stock in a registered and direct offering and warrants to purchase shares in a concurrent private placement. More news on: Hancock Jaffe Laboratories,...

IRVINE, CA / ACCESSWIRE / June 1, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI)(NASDAQ:HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today it has entered into a securities purchase agreement with certain accredited institutional investor...

Companies Sign Non-Binding Letter of Intent to Merge IRVINE, CA / ACCESSWIRE / June 1, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the Company has signed a non-binding letter of in...

CoreoGraft Study Approved by the Superintendent of Health of the National Health Council of Paraguay IRVINE, CA / ACCESSWIRE / May 12, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that ...

VenoValve Patients Continue to Show Significant Improvement at One Year IRVINE, CA / ACCESSWIRE / April 28, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI)(NASDAQ:HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that five VenoV...

IRVINE, CA / ACCESSWIRE / April 27, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI)(NASDAQ:HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today it has entered into a securities purchase agreement with certain accredited institutional invest...

Updated VenoValve data will include 8 Patients at 180 days - including 1 Patient at 365 Days Post VenoValve Surgery IRVINE, CA / ACCESSWIRE / February 26, 2020 / Hancock Jaffe Laboratories, Inc. (Nasdaq:HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular hea...

Grafts Open and Fully Functional at 6 Months IRVINE, CA / ACCESSWIRE / January 8, 2020 / Hancock Jaffe Laboratories, Inc. (Nasdaq:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced positive results from its six (6) month CoreoGraft animal f...